Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma-Reference-Cited by-同舟云学术

Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma

Published:2016-12-29 Issue: Volume: Page:now257
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:NEUONC

Author:

Reardon David A.,Lassman Andrew B.,van den Bent Martin,Kumthekar Priya,Merrell Ryan,Scott Andrew M.,Fichtel Lisa,Sulman Erik P.,Gomez Erica,Fischer JuDee,Lee Ho-Jin,Munasinghe Wijith,Xiong Hao,Mandich Helen,Roberts-Rapp Lisa,Ansell Peter,Holen Kyle D.,Gan Hui K.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Clinical Neurology,Oncology

Reference50 articles.

1. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012

2. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

3. Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma

4. LB-05PHASE III TRIAL EXPLORING THE COMBINATION OF BEVACIZUMAB AND LOMUSTINE IN PATIENTS WITH FIRST RECURRENCE OF A GLIOBLASTOMA: THE EORTC 26101 TRIAL

5. The Somatic Genomic Landscape of Glioblastoma

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming Resistance to Temozolomide in Glioblastoma: A Scoping Review of Preclinical and Clinical Data;Life;2024-05-24

2. Bystander Effects, Pharmacokinetics, and Linker-Payload Stability of EGFR-Targeting Antibody-Drug Conjugates Losatuxizumab Vedotin and Depatux-M in Glioblastoma Models;Clinical Cancer Research;2024-05-14

3. Novel Clinical Trials and Approaches in the Management of Glioblastoma;Current Oncology Reports;2024-03-28

4. Insights into the glioblastoma tumor microenvironment: current and emerging therapeutic approaches;Frontiers in Pharmacology;2024-03-08

5. Toxic warhead-armed antibody for targeted treatment of glioblastoma;Critical Reviews in Oncology/Hematology;2024-01